The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients.
Publication year
2012Source
Supportive Care in Cancer, 20, 2, (2012), pp. 319-324ISSN
Annotation
1 februari 2012
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Primary and Community Care
Anesthesiology
Psychiatry
Medical Psychology
Journal title
Supportive Care in Cancer
Volume
vol. 20
Issue
iss. 2
Page start
p. 319
Page end
p. 324
Subject
NCEBP 7: Effective primary care and public health; NCEBP 7: Effective primary care and public health ONCOL 2: Age-related aspects of cancer; NCEBP 8: Psychological determinants of chronic illness ONCOL 4: Quality of Care; NCEBP 9: Mental health; DCN MP - Plasticity and memory NCEBP 7: Effective primary care and public healthAbstract
PURPOSE: Depression is highly prevalent in advanced cancer patients, but the diagnosis of depressive disorder in patients with advanced cancer is difficult. Screening instruments could facilitate diagnosing depressive disorder in patients with advanced cancer. The aim of this study was to determine the validity of the Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in advanced cancer patients. METHODS: Patients with advanced metastatic disease, visiting the outpatient palliative care department, were asked to fill out a self-questionnaire containing the Beck Depression Inventory (BDI-II) and a single screening question "Are you feeling depressed?" The mood section of the PRIME-MD was used as a gold standard. RESULTS: Sixty-one patients with advanced metastatic disease were eligible to be included in the study. Complete data were obtained from 46 patients. The area under the curve of the receiver operating characteristics analysis of the BDI-II was 0.82. The optimal cut-off point of the BDI-II was 16 with a sensitivity of 90% and a specificity of 69%. The single screening question showed a sensitivity of 50% and a specificity of 94%. CONCLUSIONS: The BDI-II seems an adequate screening tool for a depressive disorder in advanced cancer patients. The sensitivity of a single screening question is poor.
This item appears in the following Collection(s)
- Academic publications [203812]
- Faculty of Medical Sciences [80326]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.